Analysis of status and countermeasures of cancer incidence and mortality in China
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of status and countermeasures of cancer incidence and mortality in China
Authors
Keywords
cancer, incidence, mortality, cancer spectrum, countermeasures
Journal
Science China-Life Sciences
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-21
DOI
10.1007/s11427-018-9461-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- Cancer incidence and mortality in China, 2014
- (2018) Wanqing Chen et al. Chinese Journal of Cancer Research
- BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141
- (2018) Yukun Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Estrogen Receptor‐Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance
- (2018) Adam M. Brufsky et al. ONCOLOGIST
- BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer
- (2018) Weihong Niu et al. Cell Death & Disease
- Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
- (2018) Hongmei Zeng et al. Lancet Global Health
- Long non-coding RNA LOC284454 promotes migration and invasion of nasopharyngeal carcinoma via modulating the Rho/Rac signaling pathway
- (2018) Chunmei Fan et al. CARCINOGENESIS
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway
- (2018) Yu Lian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Effects of tumor metabolic microenvironment on regulatory T cells
- (2018) Yi-an Wang et al. Molecular Cancer
- How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013
- (2017) Louise F. Wilson et al. INTERNATIONAL JOURNAL OF CANCER
- Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development
- (2017) Qiaoni Shi et al. Science China-Life Sciences
- STING-mediated DNA sensing in cancer immunotherapy
- (2017) Xiang Zhou et al. Science China-Life Sciences
- APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells
- (2017) Shuran Li et al. Science China-Life Sciences
- Targeting sphingosine-1-phosphate signaling for cancer therapy
- (2017) Zuoquan Xie et al. Science China-Life Sciences
- The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy
- (2017) Riyao Yang et al. Science China-Life Sciences
- Formation and repair of DNA-protein crosslink damage
- (2017) Naeh L. Klages-Mundt et al. Science China-Life Sciences
- The oxidative DNA damage response: A review of research undertaken with Tsinghua and Xiangya students at the University of Pittsburgh
- (2017) Arthur S. Levine et al. Science China-Life Sciences
- Epidemic trend, screening, and early detection and treatment of cancer in Chinese population
- (2017) Zou Xiao-Nong et al. Cancer Biology & Medicine
- Characteristics of breast cancer in Central China, literature review and comparison with USA
- (2016) Chuang Chen et al. BREAST
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Endocrine treatment in breast cancer: Cure, resistance and beyond
- (2016) Konstantinos Tryfonidis et al. CANCER TREATMENT REVIEWS
- BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathway
- (2016) Ran Zhao et al. Cellular & Molecular Immunology
- Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study
- (2016) Xiaosong Chen et al. Chinese Journal of Cancer Research
- Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
- (2016) Maigeng Zhou et al. LANCET
- Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer
- (2016) Hope S. Rugo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
- (2016) Katalin Boér OncoTargets and Therapy
- miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma
- (2016) Y Liu et al. Cell Death & Disease
- Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study
- (2016) Ke Wang et al. PLoS One
- Outcome-based health equity across different social health insurance schemes for the elderly in China
- (2015) Xiaoting Liu et al. BMC HEALTH SERVICES RESEARCH
- Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China
- (2015) Wen-Qiang Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- China national lung cancer screening guideline with low-dose computed tomography (2015 version)
- (2015) Qing-hua Zhou et al. Thoracic Cancer
- Esophageal/Gastric Cancer Screening in High-risk Populations in Henan Province, China
- (2014) Yu-Fei Lu et al. Asian Pacific Journal of Cancer Prevention
- Cancer survival in China, 2003-2005: A population-based study
- (2014) Hongmei Zeng et al. INTERNATIONAL JOURNAL OF CANCER
- Breast cancer in China
- (2014) Lei Fan et al. LANCET ONCOLOGY
- Challenges to effective cancer control in China, India, and Russia
- (2014) Paul E Goss et al. LANCET ONCOLOGY
- CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
- (2013) Hiroshi Katoh et al. CANCER CELL
- Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
- (2013) Gonghuan Yang et al. LANCET
- Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy
- (2011) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started